NATURECELL CO.,LTD.
Manufactures food, beverages, and cosmetics; researches stem cell therapies.
007390 | KO
Overview
Corporate Details
- ISIN(s):
- KR7007390008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 국회대로76길 10 5층, 서울특별시
- Website:
- http://en.naturecell.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other food products
Description
NATURECELL CO.,LTD. is a diversified company operating across the food, beverage, cosmetics, and biotechnology sectors. The company manufactures and sells a range of products including canned goods, health functional foods, and fruit juices. In addition to its consumer goods, NATURECELL has a significant focus on its high-tech biotechnology division, which is dedicated to stem cell research and development. This division conducts clinical trials for potential therapeutic applications, with a noted emphasis on treatments for degenerative diseases such as Alzheimer's.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-19 00:00 |
사업보고서 (2020.12)
|
Korean | 538.6 KB | ||
| 2021-03-12 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.3 KB | ||
| 2021-03-12 00:00 |
주주총회소집공고
|
Korean | 163.7 KB | ||
| 2021-03-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2021-02-26 00:00 |
전환가액의조정
|
Korean | 12.3 KB | ||
| 2021-02-17 00:00 |
기타경영사항(특허권취득)(자율공시)(소변 유래 줄기세포의 미분화능을 유지하는 방법)
|
Korean | 6.1 KB | ||
| 2021-02-09 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.8 KB | ||
| 2021-02-09 00:00 |
주주총회소집결의
|
Korean | 14.9 KB | ||
| 2021-02-03 00:00 |
투자판단관련주요경영사항(코로나바이러스-19 감염으로 인한 폐렴 환자에게서 동종 지방유래 중간엽 줄기세포치료제 아스트로스템-V의 안전성 및 유효…
|
Korean | 8.6 KB | ||
| 2021-01-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-11-26 00:00 |
전환가액의조정(제3회차)
|
Korean | 12.5 KB | ||
| 2020-11-13 00:00 |
분기보고서 (2020.09)
|
Korean | 1.3 MB | ||
| 2020-11-03 00:00 |
투자판단관련주요경영사항(코로나바이러스-19 감염으로 인한 폐렴 환자에게서 동종 지방유래 중간엽 줄기세포치료제 아스트로스템-V의 안전성 및 유효…
|
Korean | 9.1 KB | ||
| 2020-10-26 00:00 |
전환가액의조정(제3회차)
|
Korean | 12.2 KB |
Automate Your Workflow. Get a real-time feed of all NATURECELL CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NATURECELL CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NATURECELL CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
